Prolapse surgery combination may lead to stress urinary continence treatment failure in older women

Article

Compared with younger women, older women who undergo combined surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are almost twice as likely to experience SUI (but not POP) treatment failure.

Compared with younger women, older women who undergo combined surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are almost twice as likely to experience SUI (but not POP) treatment failure.

However, older women report just as significant an improvement in symptoms and effect on quality of life as younger women do, according to the findings of a retrospective cohort study involving 122 women younger than 65 years of age and 70 women 65 years of age or older.

After a median follow-up time of almost 1 year, no significant difference existed between the 2 groups.

Twenty-one percent of the older women and 11% of the younger women reported SUI treatment failure (adjusted odds ratio [AOR], 1.10; 95% confidence interval [CI], 1.05-2.5), whereas 13% of the older women and 9% of the younger women reported POP treatment failure (AOR, 0.90; 95% CI, 0.29-2.8).

Sung VW, Joo K, Marques F, Myers DL. Patient-reported outcomes after combined surgery for pelvic floor disorders in older compared to younger women. Am J Obstet Gynecol. 2009;201(5):534. e1-e5.

Recent Videos
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Lisa Bayer, MD, MPH
Megan Wasson, DO, FACOG
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Wasson and Colak
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.